Hepatobiliary complications of immune checkpoint inhibitors in cancer
Immune checkpoint inhibitors (ICIs) have dramatically changed the landscape of cancer therapy. Over the last decade, both their primary focus in trials and clinical application have exponentially risen, with repeated demonstrations of their efficacy in improving survival in various cancer types. The...
Збережено в:
| Автори: | , , |
|---|---|
| Формат: | Artigo |
| Мова: | Inglês |
| Опубліковано: |
Open Exploration Publishing Inc.
2024-07-01
|
| Серія: | Exploration of Targeted Anti-tumor Therapy |
| Предмети: | |
| Онлайн доступ: | https://www.explorationpub.com/Journals/etat/Article/1002257 |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|
